{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:16:50Z","timestamp":1791245810473,"version":"4.1.0"},"reference-count":235,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Aspects of Medicine"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.mam.2025.101347","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T19:57:37Z","timestamp":1741982257000},"page":"101347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Duration of systemic antifungal therapy for patients with invasive fungal diseases: A reassessment"],"prefix":"10.1016","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4993-6956","authenticated-orcid":false,"given":"Simon B.","family":"Gressens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Rouzaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Lamoth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Calandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Lanternier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lortholary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.mam.2025.101347_bib1","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/BF01713042","article-title":"A randomized study comparing fluconazole with amphotericin B\/5-Flucytosine for the treatment of systemicCandida infections in intensive care patients","volume":"24","author":"Abele-Horn","year":"1996","journal-title":"Infection"},{"issue":"1","key":"10.1016\/j.mam.2025.101347_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1310\/NQXR-ULMG-MM1B-3T2B","article-title":"Clinical utility of monitoring serum cryptococcal antigen (sCRAG) titers in patients with AIDS-related cryptococcal disease","volume":"1","author":"Aberg","year":"2000","journal-title":"HIV Clin. Trials"},{"issue":"3","key":"10.1016\/j.mam.2025.101347_bib3","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10096-019-03477-3","article-title":"Persistent candidemia in adults: underlying causes and clinical significance in the antifungal stewardship era","volume":"38","author":"Agnelli","year":"2019","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"9","key":"10.1016\/j.mam.2025.101347_bib4","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1093\/cid\/ciz555","article-title":"Clinical relevance and prognostic value of persistently negative (1,3)-\u03b2-D-glucan in adults with candidemia: a 5-year experience in a tertiary hospital","volume":"70","author":"Agnelli","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"Suppl. ment_2","key":"10.1016\/j.mam.2025.101347_bib5","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1093\/cid\/ciaa1855","article-title":"Guidance on imaging for invasive pulmonary aspergillosis and mucormycosis: from the imaging working group for the revision and update of the consensus definitions of fungal disease from the EORTC\/MSGERC","volume":"72","author":"Alexander","year":"2021","journal-title":"Clin. Infect. Dis."},{"issue":"10","key":"10.1016\/j.mam.2025.101347_bib6","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1086\/514352","article-title":"Trial design for mold-active agents: time to break the mold\u2014aspergillosis in neutropenic adults","volume":"44","author":"Anaissie","year":"2007","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.mam.2025.101347_bib7","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw128","article-title":"Prospective evaluation of serum \u03b2-glucan testing in patients with probable or proven fungal diseases","volume":"3","author":"Angebault","year":"2016","journal-title":"Open Forum Infect. Dis."},{"issue":"11","key":"10.1016\/j.mam.2025.101347_bib8","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3390\/jof8111121","article-title":"Ibrexafungerp, a novel triterpenoid antifungal in development for the treatment of mold infections","volume":"8","author":"Angulo","year":"2022","journal-title":"J. Fungi"},{"issue":"1","key":"10.1016\/j.mam.2025.101347_bib9","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00259-018-4192-z","article-title":"Role of FDG PET\/CT in monitoring treatment response in patients with invasive fungal infections","volume":"46","author":"Ankrah","year":"2019","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"issue":"1","key":"10.1016\/j.mam.2025.101347_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics11010137","article-title":"The added value of [18F]FDG PET\/CT in the management of invasive fungal infections","volume":"11","author":"Ankrah","year":"2021","journal-title":"Diagnostics"},{"issue":"3","key":"10.1016\/j.mam.2025.101347_bib11","first-page":"823","article-title":"Prospective evaluation of clinical and biological markers to predict the outcome of invasive pulmonary aspergillosis in hematological patients","volume":"50","author":"Anne","year":"2020","journal-title":"J. Clin. Microbiol."},{"issue":"11","key":"10.1016\/j.mam.2025.101347_bib12","doi-asserted-by":"crossref","first-page":"5828","DOI":"10.1128\/JCM.43.11.5828-5829.2005","article-title":"The role of cryptococcal antigen assay in diagnosis and monitoring of cryptococcal meningitis","volume":"43","author":"Antinori","year":"2005","journal-title":"J. Clin. Microbiol."},{"issue":"9","key":"10.1016\/j.mam.2025.101347_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13543","article-title":"Cryptococcosis in solid organ transplantation\u2014guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Baddley","year":"2019","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.mam.2025.101347_bib14","series-title":"Emerging Transplant Infections","first-page":"1","article-title":"Management of cryptococcosis in transplant candidates and recipients","author":"Baddley","year":"2020"},{"issue":"5","key":"10.1016\/j.mam.2025.101347_bib15","doi-asserted-by":"crossref","DOI":"10.1097\/MCC.0000000000000758","article-title":"Adequate duration of therapy in severe fungal infections","volume":"26","author":"Bassetti","year":"2020","journal-title":"Curr. Opin. Crit. Care"},{"issue":"12","key":"10.1016\/j.mam.2025.101347_bib16","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1111\/myc.13376","article-title":"Increasing morbidity and mortality of candidemia over one decade in a Swiss university hospital","volume":"64","author":"Battistolo","year":"2021","journal-title":"Mycoses"},{"issue":"6","key":"10.1016\/j.mam.2025.101347_bib17","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0002-9343(94)90346-8","article-title":"The continuing utility of bronchoalveolar lavage to diagnose opportunistic infection in AIDS patients","volume":"97","author":"Baughman","year":"1994","journal-title":"Am. J. Med."},{"issue":"7","key":"10.1016\/j.mam.2025.101347_bib18","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/thx.2010.155515","article-title":"Pulmonary aspergillosis: an alternative diagnosis to lung cancer after positive [18F]FDG positron emission tomography","volume":"66","author":"Baxter","year":"2011","journal-title":"Thorax"},{"issue":"8","key":"10.1016\/j.mam.2025.101347_bib19","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s40265-019-01127-8","article-title":"Adverse effects associated with long-term administration of azole antifungal agents","volume":"79","author":"Benitez","year":"2019","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.mam.2025.101347_bib20","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1056\/NEJM197907193010303","article-title":"A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis","volume":"301","author":"Bennett","year":"1979","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.mam.2025.101347_bib21","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00134-022-06733-x","article-title":"(1 \u2192 3)-\u03b2-d-Glucan-Guided antifungal therapy in adults with sepsis: the CandiSep randomized clinical trial","volume":"48","author":"Bloos","year":"2022","journal-title":"Intensive Care Med."},{"issue":"8","key":"10.1016\/j.mam.2025.101347_bib22","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/myc.12624","article-title":"Prevalence of the reversed halo sign in neutropenic patients compared with non-neutropenic patients: data from a single-centre study involving 27 patients with pulmonary mucormycosis (2003-2016)","volume":"60","author":"Bourcier","year":"2017","journal-title":"Mycoses"},{"issue":"4","key":"10.1016\/j.mam.2025.101347_bib23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1086\/341401","article-title":"A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients","volume":"35","author":"Bowden","year":"2002","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.mam.2025.101347_bib24","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2214\/AJR.05.0513","article-title":"Long-term CT follow-up in 40 non-HIV immunocompromised patients with invasive pulmonary aspergillosis: kinetics of CT morphology and correlation with clinical findings and outcome","volume":"187","author":"Brodoefel","year":"2006","journal-title":"Am. J. Roentgenol."},{"issue":"4","key":"10.1016\/j.mam.2025.101347_bib25","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1086\/432073","article-title":"Baseline correlation and comparative kinetics of cerebrospinal fluid colony\u2010forming unit counts and antigen titers in cryptococcal meningitis","volume":"192","author":"Brouwer","year":"2005","journal-title":"J. Infect. Dis."},{"issue":"165","key":"10.1016\/j.mam.2025.101347_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"7","key":"10.1016\/j.mam.2025.101347_bib27","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1086\/500212","article-title":"Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases","volume":"42","author":"Burik","year":"2006","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.mam.2025.101347_bib28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1200\/JCO.2001.19.1.253","article-title":"Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia","volume":"19","author":"Caillot","year":"2001","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.mam.2025.101347_bib29","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.1016\/j.ejrad.2009.05.058","article-title":"Computer tomography in pulmonary invasive aspergillosis in hematological patients with neutropenia: an useful tool for diagnosis and assessment of outcome in clinical trials","volume":"74","author":"Caillot","year":"2010","journal-title":"Eur. J. Radiol."},{"issue":"4","key":"10.1016\/j.mam.2025.101347_bib30","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/cid\/ciu337","article-title":"Immune correlates of protection in human invasive aspergillosis","volume":"59","author":"Camargo","year":"2014","journal-title":"Clin. Infect. Dis."},{"issue":"7","key":"10.1016\/j.mam.2025.101347_bib31","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1128\/JCM.06513-11","article-title":"Early serum galactomannan trend as a predictor of outcome of invasive aspergillosis","volume":"50","author":"Chai Louis","year":"2020","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.mam.2025.101347_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(23)00731-4","article-title":"Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM","author":"Chang","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.mam.2025.101347_bib33","doi-asserted-by":"crossref","DOI":"10.5152\/dir.2013.13183","article-title":"Sequential morphological changes in follow-up CT of pulmonary mucormycosis","author":"Choo","year":"2013","journal-title":"Diagn. Interv. Radiol."},{"issue":"April","key":"10.1016\/j.mam.2025.101347_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12569","article-title":"European society of clinical microbiology and infectious diseases (ESCMID) fungal infection study group (EFISG) and European confederation of medical mycology (ECMM) 2013 joint guidelines on diagnosis and management of rare and emerging fungal diseases","volume":"20","author":"Cornely","year":"2014","journal-title":"Clin. Microbiol. Infection"},{"issue":"12","key":"10.1016\/j.mam.2025.101347_bib35","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the European confederation of medical mycology in cooperation with the Mycoses study group education and research consortium","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect. Dis."},{"issue":"6","key":"10.1016\/j.mam.2025.101347_bib36","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/myc.12755","article-title":"Role of Bi-weekly serum galactomannan screening for the diagnosis of invasive aspergillosis in haematological cancer patients","volume":"61","author":"Couchepin","year":"2018","journal-title":"Mycoses"},{"issue":"6","key":"10.1016\/j.mam.2025.101347_bib37","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/QCO.0000000000000976","article-title":"Mucormycosis: update on clinical presentation, diagnosis, and treatment","volume":"36","author":"Dailey","year":"2023","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.mam.2025.101347_bib38","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00134-017-4737-9","article-title":"Catheter retention as a consequence rather than a cause of unfavorable outcome in candidemia","volume":"43","author":"Damonti","year":"2017","journal-title":"Intensive Care Med."},{"issue":"5","key":"10.1016\/j.mam.2025.101347_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/jof8050457","article-title":"Recent developments in the diagnosis of mucormycosis","volume":"8","author":"Dannaoui","year":"2022","journal-title":"J. Fungi"},{"issue":"5","key":"10.1016\/j.mam.2025.101347_bib40","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/S0012-3692(15)33416-4","article-title":"Pneumocystis carinii pneumonia\u2217: the time course of clinical and radiographic improvement","volume":"124","author":"Datta","year":"2003","journal-title":"Chest"},{"issue":"February","key":"10.1016\/j.mam.2025.101347_bib41","article-title":"Risk of candidiasis associated with interleukin-17 inhibitors: a real-world observational study of multiple independent sources","volume":"13","author":"Davidson","year":"2022","journal-title":"Lancet Region. Health \u2013 Europe"},{"issue":"4","key":"10.1016\/j.mam.2025.101347_bib42","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.02094-19","article-title":"Efficacy of cerebrospinal fluid beta- d -glucan diagnostic testing for fungal meningitis: a systematic review","volume":"58","author":"Davis","year":"2020","journal-title":"J. Clin. Microbiol."},{"issue":"14","key":"10.1016\/j.mam.2025.101347_bib43","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJMoa1110404","article-title":"Combination antifungal therapy for cryptococcal meningitis","volume":"368","author":"Day","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.mam.2025.101347_bib44","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1378\/chest.91.3.323","article-title":"Roentgenographic patterns of Pneumocystis carinii pneumonia in 104 patients with AIDS","volume":"91","author":"DeLorenzo","year":"1987","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.mam.2025.101347_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094183","article-title":"Critical importance of long-term adherence to care in HIV infected patients in the cART era: new insights from Pneumocystis jirovecii pneumonia cases over 2004-2011 in the FHDH-ANRS CO4 cohort","volume":"9","author":"Denis","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.mam.2025.101347_bib46","article-title":"Global incidence and mortality of severe fungal disease","author":"Denning","year":"2024","journal-title":"Lancet Infect. Dis."},{"issue":"2","key":"10.1016\/j.mam.2025.101347_bib47","doi-asserted-by":"crossref","first-page":"176","DOI":"10.7326\/0003-4819-80-2-176","article-title":"Prognostic factors in cryptococcal meningitis: a study in 111 cases","volume":"80","author":"Diamond","year":"1974","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"10.1016\/j.mam.2025.101347_bib48","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1056\/NEJM198708063170602","article-title":"Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks","volume":"317","author":"Dismukes","year":"1987","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.mam.2025.101347_bib49","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the Mycoses study group education and research consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"8","key":"10.1016\/j.mam.2025.101347_bib50","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1164\/rccm.201305-0884LE","article-title":"Reply: continuous infusion of amphotericin B deoxycholate for the treatment of life-threatening Candida infections","volume":"188","author":"Dreyfuss","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.mam.2025.101347_bib51","article-title":"The current state of clinical mycology in eastern and South-Eastern Europe","volume":"60","author":"Driemeyer","year":"2022","journal-title":"Med. Mycol."},{"issue":"2","key":"10.1016\/j.mam.2025.101347_bib52","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1371\/journal.pmed.0040021","article-title":"Determinants of disease presentation and outcome during cryptococcosis: the CryptoA\/D study","volume":"4","author":"Dromer","year":"2007","journal-title":"PLoS Med."},{"issue":"8","key":"10.1016\/j.mam.2025.101347_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002870","article-title":"Major role for amphotericin B\u2013flucytosine combination in severe cryptococcosis","volume":"3","author":"Dromer","year":"2008","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.mam.2025.101347_bib54","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/cid\/civ495","article-title":"Desirability of outcome ranking (DOOR) and response adjusted for duration of antibiotic risk (RADAR)","volume":"61","author":"Evans","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.mam.2025.101347_bib55","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/cid\/ciz1195","article-title":"How long do we need to treat an invasive mold disease in hematology patients? Factors influencing duration of therapy and future questions","volume":"71","author":"Fern\u00e1ndez-Cruz","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.mam.2025.101347_bib56","first-page":"345","article-title":"The role of olorofim in the treatment of filamentous fungal infections: a review of in vitro and in vivo studies","volume":"10","author":"Feuss","year":"2024","journal-title":"J. Fungi (Basel, Switzerland)"},{"issue":"6","key":"10.1016\/j.mam.2025.101347_bib57","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1086\/313499","article-title":"A pilot study of the management of uncomplicated candidemia with a standardized protocol of amphotericin B","volume":"29","author":"Fichtenbaum","year":"1999","journal-title":"Clin. Infect. Dis."},{"issue":"9","key":"10.1016\/j.mam.2025.101347_bib58","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13587","article-title":"Pneumocystis jiroveci in solid organ transplantation: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Fishman","year":"2019","journal-title":"Clin. Transplant."},{"issue":"7","key":"10.1016\/j.mam.2025.101347_bib59","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1086\/339324","article-title":"Invasive aspergillosis in allogeneic stem cell transplant recipients: increasing antigenemia is associated with progressive disease","volume":"34","author":"Fran\u00e7ois","year":"2002","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.mam.2025.101347_bib60","doi-asserted-by":"crossref","DOI":"10.1097\/00003072-200103000-00011","article-title":"Therapy monitoring in aspergillosis using F-18 FDG positron emission tomography","volume":"26","author":"Franzius","year":"2001","journal-title":"Clin. Nucl. Med."},{"issue":"3","key":"10.1016\/j.mam.2025.101347_bib61","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003281","article-title":"Invasive fungal diseases in patients with autoimmune diseases: a case series from the French RESSIF network","volume":"9","author":"Galmiche","year":"2023","journal-title":"RMD Open"},{"issue":"4","key":"10.1016\/j.mam.2025.101347_bib62","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/cid\/ciz1051","article-title":"Prognostic impact of negative serum (1,3)-\u03b2-D-glucan in patients with candidemia","volume":"71","author":"Giacobbe","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.mam.2025.101347_bib63","doi-asserted-by":"crossref","first-page":"e725","DOI":"10.1542\/peds.2004-2157","article-title":"What caused the epidemic of Pneumocystis pneumonia in European premature infants in the Mid-20th Century?","volume":"115","author":"Goldman","year":"2005","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.mam.2025.101347_bib64","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1128\/AAC.50.1.126-133.2006","article-title":"Posaconazole as salvage therapy for Zygomycosis","volume":"50","author":"Greenberg","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.mam.2025.101347_bib65","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1086\/322787","article-title":"In vivo clearance of Glucuronoxylomannan, the major Capsular polysaccharide of Cryptococcus neoformans: a critical role for tissue macrophages","volume":"184","author":"Grinsell","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.mam.2025.101347_bib66","series-title":"Preventing and Managing Cryptococcal Disease Among Adults, Adolescents and Children Living with HIV","year":"2022"},{"issue":"5","key":"10.1016\/j.mam.2025.101347_bib67","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jinf.2018.01.011","article-title":"Usefulness of SS-D-Glucan for diagnosis and follow-up of invasive candidiasis in onco-haematological patients","volume":"76","author":"Guitard","year":"2018","journal-title":"J. Infect."},{"issue":"4","key":"10.1016\/j.mam.2025.101347_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/jof6040338","article-title":"Advances in the in vivo molecular imaging of invasive aspergillosis","volume":"6","author":"Gunzer","year":"2020","journal-title":"J. Fungi"},{"issue":"3","key":"10.1016\/j.mam.2025.101347_bib69","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0002-9343(84)90670-3","article-title":"Assessment of therapy for Pneumocystis carinii pneumonia: PCP therapy Project group","volume":"76","author":"Haverkos","year":"1984","journal-title":"Am. J. Med."},{"issue":"6","key":"10.1016\/j.mam.2025.101347_bib70","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/myc.12860","article-title":"Diagnostic work up to assess early response indicators in invasive pulmonary aspergillosis in adult patients with haematologic malignancies","volume":"62","author":"Heinz","year":"2019","journal-title":"Mycoses"},{"issue":"7","key":"10.1016\/j.mam.2025.101347_bib71","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/j.1469-0691.2010.03452.x","article-title":"\u03b2-d-Glucan kinetics for the assessment of treatment response in Pneumocystis jirovecii pneumonia","volume":"17","author":"Held","year":"2011","journal-title":"Clin. Microbiol. Infection"},{"issue":"6","key":"10.1016\/j.mam.2025.101347_bib72","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/jac\/dkp372","article-title":"Clinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis jirovecii pneumonia: a Tri-centre cohort study","volume":"64","author":"Helweg-Larsen","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"issue":"4","key":"10.1016\/j.mam.2025.101347_bib73","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/QCO.0000000000000458","article-title":"Treatment of cryptococcosis in non-HIV immunocompromised patients","volume":"31","author":"Henao-Mart\u00ednez","year":"2018","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.mam.2025.101347_bib74","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/s41467-021-21965-z","article-title":"Antibody-guided in vivo imaging of Aspergillus fumigatus lung infections during antifungal azole treatment","volume":"12","author":"Henneberg","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.mam.2025.101347_bib75","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1038\/s41598-017-04470-6","article-title":"Diagnostic performance of contrast enhanced pulmonary computed tomography angiography for the detection of angioinvasive pulmonary aspergillosis in immunocompromised patients","volume":"7","author":"Henzler","year":"2017","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.mam.2025.101347_bib76","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.mam.2025.101347_bib77","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s10096-007-0383-4","article-title":"Use of the PATH alliance database to measure adherence to IDSA guidelines for the therapy of candidemia","volume":"26","author":"Horn","year":"2007","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"3","key":"10.1016\/j.mam.2025.101347_bib79","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1469-0691.2010.03301.x","article-title":"Diagnostic contribution of positron emission tomography with [18F]fluorodeoxyglucose for invasive fungal infections","volume":"17","author":"Hot","year":"2011","journal-title":"Clin. Microbiol. Infection"},{"issue":"2","key":"10.1016\/j.mam.2025.101347_bib80","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0022-3476(78)80028-6","article-title":"Comparison of pentamidine isethionate andtrimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia","volume":"92","author":"Hughes","year":"1978","journal-title":"J. Pediatr."},{"issue":"2","key":"10.1016\/j.mam.2025.101347_bib81","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1128\/AAC.49.2.721-727.2005","article-title":"Caspofungin inhibits rhizopus oryzae 1,3-\u03b2-d-Glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated Zygomycosis","volume":"49","author":"Ibrahim","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.mam.2025.101347_bib82","doi-asserted-by":"crossref","first-page":"562.e1","DOI":"10.1016\/j.cmi.2016.01.027","article-title":"Aspergillus PCR in serum for the diagnosis, follow-up and prognosis of invasive aspergillosis in neutropenic and Nonneutropenic patients","volume":"22","author":"Imbert","year":"2016","journal-title":"Clin. Microbiol. Infection"},{"issue":"5","key":"10.1016\/j.mam.2025.101347_bib83","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13896","article-title":"Shorter is better: the case for short antibiotic courses for common infections in solid organ transplant recipients","volume":"24","author":"Imlay","year":"2022","journal-title":"Transpl. Infect. Dis."},{"issue":"April","key":"10.1016\/j.mam.2025.101347_bib84","article-title":"Gut leakage of fungal\u2010related products: turning up the heat for HIV infection","volume":"12","author":"Isnard","year":"2021","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.mam.2025.101347_bib85","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/cid\/cis456","article-title":"(1,3)-\u03b2-D-Glucan as a prognostic marker of treatment response in invasive candidiasis","volume":"55","author":"Jaijakul","year":"2012","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.mam.2025.101347_bib86","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/cid\/cit794","article-title":"Determinants of mortality in a combined cohort of 501 patients with HIV-associated cryptococcal meningitis: implications for improving outcomes","volume":"58","author":"Jarvis","year":"2014","journal-title":"Clin. Infect. Dis."},{"issue":"12","key":"10.1016\/j.mam.2025.101347_bib87","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1056\/NEJMoa2111904","article-title":"Single-dose liposomal amphotericin B treatment for cryptococcal meningitis","volume":"386","author":"Jarvis","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mam.2025.101347_bib88","article-title":"Adherence to national consensus guidelines and association with clinical outcomes in patients with candidemia","volume":"14","author":"Junco","year":"2021","journal-title":"Infect. Dis."},{"issue":"1","key":"10.1016\/j.mam.2025.101347_bib89","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/cid\/cit641","article-title":"Point-of-Care diagnosis and prognostication of cryptococcal meningitis with the cryptococcal antigen lateral flow assay on cerebrospinal fluid","volume":"58","author":"Kabanda","year":"2014","journal-title":"Clin. Infect. Dis."},{"issue":"9","key":"10.1016\/j.mam.2025.101347_bib90","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac416","article-title":"Therapeutic lumbar punctures in human immunodeficiency virus\u2013associated cryptococcal meningitis: should opening pressure direct management?","volume":"9","author":"Kagimu","year":"2022","journal-title":"Open Forum Infect. Dis."},{"issue":"Suppl. ment_1","key":"10.1016\/j.mam.2025.101347_bib91","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1086\/313843","article-title":"Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy","volume":"30","author":"Kaplan","year":"2000","journal-title":"Clin. Infect. Dis."},{"issue":"13","key":"10.1016\/j.mam.2025.101347_bib92","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.2169\/internalmedicine.50.5296","article-title":"Kinetics of serum \u03b2-D-glucan after Pneumocystis pneumonia treatment in patients with AIDS","volume":"50","author":"Koga","year":"2011","journal-title":"Intern. Med."},{"issue":"July","key":"10.1016\/j.mam.2025.101347_bib93","article-title":"Evolving epidemiology of Pneumocystis pneumonia: findings from a longitudinal population-based study and a retrospective multi-center study in Germany","volume":"18","author":"Kolbrink","year":"2022","journal-title":"Lancet Region. Health \u2013 Europe"},{"issue":"5","key":"10.1016\/j.mam.2025.101347_bib94","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1182\/blood-2011-03-316430","article-title":"How I treat mucormycosis","volume":"118","author":"Kontoyiannis","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.mam.2025.101347_bib95","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1128\/AAC.00990-07","article-title":"Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis","volume":"52","author":"Kontoyiannis","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.mam.2025.101347_bib96","doi-asserted-by":"crossref","first-page":"E122","DOI":"10.1111\/j.1469-0691.2012.03777.x","article-title":"Post-diagnostic kinetics of the (1 \u2192 3)-\u03b2-d-Glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia","volume":"18","author":"Koo","year":"2012","journal-title":"Clin. Microbiol. Infection"},{"issue":"3","key":"10.1016\/j.mam.2025.101347_bib97","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/thoraxjnl-2014-206291","article-title":"The clinical spectrum of pulmonary aspergillosis","volume":"70","author":"Kosmidis","year":"2015","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.mam.2025.101347_bib98","doi-asserted-by":"crossref","first-page":"663","DOI":"10.7326\/0003-4819-100-5-663","article-title":"Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies","volume":"100","author":"Kovacs","year":"1984","journal-title":"Ann. Intern. Med."},{"issue":"11","key":"10.1016\/j.mam.2025.101347_bib99","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1093\/cid\/cix198","article-title":"Pharmacodynamics of isavuconazole for invasive mold disease: role of galactomannan for real-time monitoring of therapeutic response","volume":"64","author":"Kovanda","year":"2017","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.mam.2025.101347_bib100","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.2214\/ajr.150.5.1015","article-title":"CT of invasive pulmonary aspergillosis","volume":"150","author":"Kuhlman","year":"1988","journal-title":"Am. J. Roentgenol."},{"issue":"9495","key":"10.1016\/j.mam.2025.101347_bib101","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0140-6736(05)67490-9","article-title":"Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial","volume":"366","author":"Kullberg","year":"2005","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.mam.2025.101347_bib102","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1093\/cid\/ciy827","article-title":"Isavuconazole versus caspofungin in the treatment of candidemia and other invasive Candida infections: the ACTIVE trial","volume":"68","author":"Kullberg","year":"2019","journal-title":"Clin. Infect. Dis."},{"issue":"9572","key":"10.1016\/j.mam.2025.101347_bib103","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(07)60605-9","article-title":"Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial","volume":"369","author":"Kuse","year":"2007","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.mam.2025.101347_bib104","doi-asserted-by":"crossref","DOI":"10.1097\/QCO.0000000000000812","article-title":"Invasive aspergillosis in coronavirus disease 2019: a practical approach for clinicians","volume":"35","author":"Lamoth","year":"2022","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"11","key":"10.1016\/j.mam.2025.101347_bib105","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1093\/jac\/dkv236","article-title":"Prospective pilot study of high-dose (10 Mg\/Kg\/Day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis","volume":"70","author":"Lanternier","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"issue":"5","key":"10.1016\/j.mam.2025.101347_bib106","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/myc.13056","article-title":"Invasive pulmonary aspergillosis treatment duration in haematology patients in Europe: an EFISG, IDWP-EBMT, EORTC-IDG and SEIFEM survey","volume":"63","author":"Lanternier","year":"2020","journal-title":"Mycoses"},{"issue":"3","key":"10.1016\/j.mam.2025.101347_bib107","doi-asserted-by":"crossref","first-page":"183","DOI":"10.7326\/0003-4819-113-3-183","article-title":"Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS: a randomized trial","volume":"113","author":"Larsen","year":"1990","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.mam.2025.101347_bib108","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.00469","article-title":"Polysaccharides cell wall architecture of Mucorales","volume":"10","author":"Lecointe","year":"2019","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.mam.2025.101347_bib109","doi-asserted-by":"crossref","DOI":"10.1093\/mmy\/myac100","article-title":"Parietal composition of Lichtheimia Corymbifera: differences between spore and germ tube stages and host-pathogen interactions","volume":"61","author":"Lecointe","year":"2022","journal-title":"Med. Mycol."},{"key":"10.1016\/j.mam.2025.101347_bib110","article-title":"Short course antibiotics for common infections: what do we know and where do we go from here?","author":"Lee","year":"2022","journal-title":"Clin. Microbiol. Infection"},{"issue":"4","key":"10.1016\/j.mam.2025.101347_bib111","doi-asserted-by":"crossref","first-page":"E99","DOI":"10.1111\/j.1469-0691.2012.03764.x","article-title":"Diagnosis, management and outcome of Candida endocarditis","volume":"18","author":"Lefort","year":"2012","journal-title":"Clin. Microbiol. Infection"},{"issue":"5","key":"10.1016\/j.mam.2025.101347_bib112","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/cid\/cit929","article-title":"The reversed halo sign: pathognomonic pattern of pulmonary mucormycosis in leukemic patients with neutropenia?","volume":"58","author":"Legouge","year":"2014","journal-title":"Clin. Infect. Dis."},{"issue":"10","key":"10.1016\/j.mam.2025.101347_bib113","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23105563","article-title":"Monoclonal antibodies and invasive aspergillosis: diagnostic and therapeutic perspectives","volume":"23","author":"Lian","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.mam.2025.101347_bib114","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/QCO.0000000000000593","article-title":"Primary immunodeficiencies and invasive fungal infection: when to suspect and how to diagnose and manage","volume":"32","author":"Lionakis","year":"2019","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"10","key":"10.1016\/j.mam.2025.101347_bib115","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/01.aids.0000174450.70874.30","article-title":"Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France","volume":"19","author":"Lortholary","year":"2005","journal-title":"AIDS"},{"issue":"17","key":"10.1016\/j.mam.2025.101347_bib116","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1097\/01.aids.0000252060.80704.68","article-title":"Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy","volume":"20","author":"Lortholary","year":"2006","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.mam.2025.101347_bib117","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1128\/JCM.02301-14","article-title":"Utility of measuring (1,3)-\u03b2- d -glucan in cerebrospinal fluid for diagnosis of fungal central nervous system infection","volume":"53","author":"Lyons","year":"2015","journal-title":"J. Clin. Microbiol."},{"issue":"7","key":"10.1016\/j.mam.2025.101347_bib118","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000549","article-title":"Genomic analysis of the basal lineage fungus rhizopus oryzae reveals a whole-genome duplication","volume":"5","author":"Ma","year":"2009","journal-title":"PLoS Genet."},{"issue":"2","key":"10.1016\/j.mam.2025.101347_bib119","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/cncr.24022","article-title":"Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients","volume":"115","author":"Maertens","year":"2009","journal-title":"Cancer"},{"issue":"10020","key":"10.1016\/j.mam.2025.101347_bib120","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet"},{"issue":"10273","key":"10.1016\/j.mam.2025.101347_bib121","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0140-6736(21)00219-1","article-title":"Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial","volume":"397","author":"Maertens","year":"2021","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.mam.2025.101347_bib122","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1473-3099(20)30266-8","article-title":"Importance of the reversed halo sign for diagnosis of mucormycosis","volume":"20","author":"Marchiori","year":"2020","journal-title":"Lancet Infect. Dis."},{"issue":"5","key":"10.1016\/j.mam.2025.101347_bib123","article-title":"Evaluation of mass spectrometry-based detection of panfungal serum disaccharide for diagnosis of invasive fungal infections: results from a collaborative study involving six European clinical Centers","volume":"57","author":"Marjorie","year":"2019","journal-title":"J. Clin. Microbiol."},{"issue":"6","key":"10.1016\/j.mam.2025.101347_bib124","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00134-019-05599-w","article-title":"ESICM\/ESCMID task force on practical management of invasive candidiasis in critically ill patients","volume":"45","author":"Martin-Loeches","year":"2019","journal-title":"Intensive Care Med."},{"issue":"1","key":"10.1016\/j.mam.2025.101347_bib125","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0000000000002011","article-title":"Impact of source control in patients with severe sepsis and septic shock","volume":"45","author":"Mart\u00ednez","year":"2017","journal-title":"Crit. Care Med."},{"issue":"1","key":"10.1016\/j.mam.2025.101347_bib126","doi-asserted-by":"crossref","first-page":"70","DOI":"10.7326\/0003-4819-147-1-200707030-00018","article-title":"(1\u21923)\u03b2-d-Glucan assay positivity in patients with Pneumocystis (carinii) Jiroveci pneumonia","volume":"147","author":"Marty","year":"2007","journal-title":"Ann. Intern. Med."},{"issue":"7","key":"10.1016\/j.mam.2025.101347_bib127","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S1473-3099(16)00071-2","article-title":"Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis","volume":"16","author":"Marty","year":"2016","journal-title":"Lancet Infect. Dis."},{"issue":"9","key":"10.1016\/j.mam.2025.101347_bib128","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1093\/jac\/dkw158","article-title":"ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients","volume":"71","author":"Maschmeyer","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/j.mam.2025.101347_bib129","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1177\/0284185120988828","article-title":"Imaging features of rhinocerebral mucormycosis: from onset to vascular complications","volume":"63","author":"Mazzai","year":"2022","journal-title":"Acta Radiol."},{"issue":"12","key":"10.1016\/j.mam.2025.101347_bib130","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1056\/NEJM199009203231202","article-title":"Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome","volume":"323","author":"Medina","year":"1990","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.mam.2025.101347_bib131","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S1473-3099(19)30405-0","article-title":"Effect of infectious disease consultation on mortality and treatment of patients with Candida bloodstream infections: a retrospective, cohort study","volume":"19","author":"Mejia-Chew","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.mam.2025.101347_bib132","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2018.00661","article-title":"Galactomannan, a surrogate marker for outcome in invasive aspergillosis: finally coming of age","volume":"9","author":"Mercier","year":"2018","journal-title":"Front. Microbiol."},{"issue":"2","key":"10.1016\/j.mam.2025.101347_bib133","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9020610","article-title":"A mortality prediction rule for hematology patients with invasive aspergillosis based on serum galactomannan kinetics","volume":"9","author":"Mercier","year":"2020","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.mam.2025.101347_bib134","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1128\/CVI.00513-10","article-title":"Persistence of a positive (1,3)-\u03b2-d-glucan test after clearance of candidemia in hematopoietic stem cell transplant recipients","volume":"18","author":"Mikulska","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"issue":"8","key":"10.1016\/j.mam.2025.101347_bib135","doi-asserted-by":"crossref","first-page":"1154.e1","DOI":"10.1016\/j.cmi.2022.02.045","article-title":"Levels of beta-D-glucan in Candida auris supernatants, an in vitro and in vivo preliminary study","volume":"28","author":"Mikulska","year":"2022","journal-title":"Clin. Microbiol. Infection"},{"issue":"5","key":"10.1016\/j.mam.2025.101347_bib136","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/jcla.1860090509","article-title":"(1\u21a03)-\u03b2-D-Glucan in culture fluid of fungi activates factor g, a limulus coagulation factor","volume":"9","author":"Miyazaki","year":"1995","journal-title":"J. Clin. Lab. Anal."},{"issue":"11","key":"10.1016\/j.mam.2025.101347_bib137","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJMoa1710922","article-title":"Antifungal combinations for treatment of cryptococcal meningitis in Africa","volume":"378","author":"Molloy","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.mam.2025.101347_bib138","doi-asserted-by":"crossref","DOI":"10.3390\/jof7030178","article-title":"T2Candida for the diagnosis and management of invasive Candida infections","volume":"7","author":"Monday","year":"2021","journal-title":"J. Fungi"},{"issue":"4","key":"10.1016\/j.mam.2025.101347_bib139","first-page":"293","article-title":"The efficacy of fluconazole 600 Mg\/day versus itraconazole 600 Mg\/day as consolidation therapy of cryptococcal meningitis in AIDS patients","volume":"86","author":"Mootsikapun","year":"2003","journal-title":"J. Med. Associat. Thailand = Chotmaihet Thangphaet."},{"issue":"25","key":"10.1016\/j.mam.2025.101347_bib140","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa021585","article-title":"Comparison of caspofungin and amphotericin B for invasive candidiasis","volume":"347","author":"Mora-Duarte","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.mam.2025.101347_bib141","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.3201\/eid1010.030985","article-title":"Current epidemiology of Pneumocystis pneumonia","volume":"10","author":"Morris","year":"2004","journal-title":"Emerg. Infect. Dis."},{"issue":"Suppl. l_4","key":"10.1016\/j.mam.2025.101347_bib142","doi-asserted-by":"crossref","first-page":"iv6","DOI":"10.1093\/jac\/dky047","article-title":"T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study","volume":"73","author":"Mu\u00f1oz","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"issue":"3","key":"10.1016\/j.mam.2025.101347_bib143","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/jgf2.159","article-title":"Antimicrobial stewardship without infectious disease physician for patients with candidemia: a before and after study","volume":"19","author":"Murakami","year":"2018","journal-title":"J. General Fam. Med."},{"issue":"4","key":"10.1016\/j.mam.2025.101347_bib144","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1086\/381261","article-title":"Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study","volume":"38","author":"Mussini","year":"2004","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.mam.2025.101347_bib145","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s00330-017-5007-5","article-title":"Pulmonary mucormycosis: serial morphologic changes on computed tomography correlate with clinical and pathologic findings","volume":"28","author":"Nam","year":"2018","journal-title":"Eur. Radiol."},{"issue":"6","key":"10.1016\/j.mam.2025.101347_bib147","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129022","article-title":"Correlation between circulating fungal biomarkers and clinical outcome in invasive aspergillosis","volume":"10","author":"Neofytos","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.mam.2025.101347_bib148","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12879-021-05958-3","article-title":"Invasive aspergillosis in solid organ transplant patients: diagnosis, prophylaxis, treatment, and assessment of response","volume":"21","author":"Neofytos","year":"2021","journal-title":"BMC Infect. Dis."},{"issue":"22","key":"10.1016\/j.mam.2025.101347_bib149","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1001\/archinte.1995.00430220087009","article-title":"Therapeutic approaches in patients with candidemia: evaluation in a multicenter, prospective, observational study","volume":"155","author":"Nguyen","year":"1995","journal-title":"Arch. Intern. Med."},{"issue":"7","key":"10.1016\/j.mam.2025.101347_bib150","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/cid\/cir441","article-title":"Earlier response assessment in invasive aspergillosis based on the kinetics of serum Aspergillus galactomannan: proposal for a new definition","volume":"53","author":"Nou\u00e9r","year":"2011","journal-title":"Clin. Infect. Dis."},{"issue":"12","key":"10.1016\/j.mam.2025.101347_bib151","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1093\/cid\/cis298","article-title":"Baseline platelet count and creatinine clearance rate predict the outcome of neutropenia-related invasive aspergillosis","volume":"54","author":"Nou\u00e9r","year":"2012","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.mam.2025.101347_bib152","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1086\/653935","article-title":"Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials","volume":"51","author":"Nucci","year":"2010","journal-title":"Clin. Infect. Dis."},{"issue":"21","key":"10.1016\/j.mam.2025.101347_bib153","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJM199011223232131","article-title":"Consensus statement on the use of corticosteroids as adjunctive therapy for Pneumocystis pneumonia in the acquired immunodeficiency syndrome","volume":"323","year":"1990","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.mam.2025.101347_bib154","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jinf.2017.12.018","article-title":"Fluconazole non-susceptible breakthrough candidemia after prolonged low-dose prophylaxis: a prospective FUNGINOS study","volume":"76","author":"Orasch","year":"2018","journal-title":"J. Infect."},{"issue":"1","key":"10.1016\/j.mam.2025.101347_bib155","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10096-002-0854-6","article-title":"Duration of antifungal treatment and development of delayed complications in patients with candidaemia","volume":"22","author":"Oude Lashof","year":"2003","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"5","key":"10.1016\/j.mam.2025.101347_bib156","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1378\/chest.114.5.1264","article-title":"Clearance of Pneumocystis carinii cysts in acute P carinii pneumonia: assessment by serial sputum induction","volume":"114","author":"O'Donnell","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.mam.2025.101347_bib157","article-title":"Cryptococcus neoformans infections differ among HIV-seropositive and HIV-seronegative individuals: results from a nationwide surveillance program in France","author":"Paccoud","year":"2023","journal-title":"Open Forum Infect. Dis."},{"issue":"8","key":"10.1016\/j.mam.2025.101347_bib158","doi-asserted-by":"crossref","first-page":"ofac383","DOI":"10.1093\/ofid\/ofac383","article-title":"\u039aey role of early source control in candidemic patients with sepsis or septic shock","volume":"9","author":"Papadimitriou-Olivgeris","year":"2022","journal-title":"Open Forum Infect. Dis."},{"issue":"4","key":"10.1016\/j.mam.2025.101347_bib159","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.mam.2025.101347_bib160","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.26","article-title":"Invasive candidiasis","volume":"4","author":"Pappas","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"6","key":"10.1016\/j.mam.2025.101347_bib161","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jinf.2011.08.007","article-title":"Computed tomography findings in invasive pulmonary aspergillosis in non-neutropenic transplant recipients and neutropenic patients, and their prognostic value","volume":"63","author":"Park","year":"2011","journal-title":"J. Infect."},{"issue":"6","key":"10.1016\/j.mam.2025.101347_bib162","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1439-0507.2010.02009.x","article-title":"Serum galactomannan strongly correlates with outcome of invasive aspergillosis in acute leukaemia patients","volume":"54","author":"Park","year":"2011","journal-title":"Mycoses"},{"issue":"4","key":"10.1016\/j.mam.2025.101347_bib163","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin. Infect. Dis."},{"issue":"12","key":"10.1016\/j.mam.2025.101347_bib164","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1016\/S1473-3099(17)30316-X","article-title":"The global problem of antifungal resistance: prevalence, mechanisms, and management","volume":"17","author":"Perlin","year":"2017","journal-title":"Lancet Infect. Dis."},{"issue":"September","key":"10.1016\/j.mam.2025.101347_bib165","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jgar.2021.04.012","article-title":"Antimicrobial activity of manogepix, a first-in-class antifungal, and comparator agents tested against contemporary invasive fungal isolates from an international surveillance programme (2018-2019)","volume":"26","author":"Pfaller","year":"2021","journal-title":"J. Glob. Antimicrob. Resist."},{"issue":"12","key":"10.1016\/j.mam.2025.101347_bib166","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1128\/JCM.43.12.5957-5962.2005","article-title":"Evaluation of a (1\u21923)-\u03b2-d-glucan assay for diagnosis of invasive fungal infections","volume":"43","author":"Pickering","year":"2005","journal-title":"J. Clin. Microbiol."},{"issue":"2","key":"10.1016\/j.mam.2025.101347_bib167","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s15010-015-0849-8","article-title":"Evaluation of serum (1 \u2192 3)-\u03b2-d-Glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors","volume":"44","author":"Pini","year":"2016","journal-title":"Infection"},{"issue":"9","key":"10.1016\/j.mam.2025.101347_bib168","doi-asserted-by":"crossref","first-page":"946","DOI":"10.3390\/jof8090946","article-title":"The changing landscape of invasive fungal infections in ICUs: a need for risk stratification to better target antifungal drugs and the threat of resistance","volume":"8","author":"Poissy","year":"2022","journal-title":"J. Fungi"},{"issue":"6","key":"10.1016\/j.mam.2025.101347_bib169","doi-asserted-by":"crossref","DOI":"10.1097\/QCO.0000000000000972","article-title":"Duration of antifungal treatment in mold infection: when is enough?","volume":"36","author":"Portillo","year":"2023","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.mam.2025.101347_bib170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149108","article-title":"Mucorales-specific T cells in patients with hematologic malignancies","volume":"11","author":"Potenza","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.mam.2025.101347_bib171","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/clinids\/18.5.789","article-title":"Measurement of cryptococcal antigen in serum and cerebrospinal fluid: value in the management of AIDS-associated cryptococcal meningitis","volume":"18","author":"Powderly","year":"1994","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.mam.2025.101347_bib172","unstructured":"Prevention and Treatment of Opportunistic Infections Among Adults and Adolescents.\u201d n.d. Accessed June 5, 2024. https:\/\/www.idsociety.org\/practice-guideline\/prevention-and-treatment-of-opportunistic-infections-among-adults-and-adolescents\/."},{"issue":"10","key":"10.1016\/j.mam.2025.101347_bib173","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3390\/jof7100848","article-title":"Changing epidemiology of invasive fungal disease in allogeneic hematopoietic stem cell transplantation","volume":"7","author":"Puerta-Alcalde","year":"2021","journal-title":"J. Fungi"},{"issue":"7","key":"10.1016\/j.mam.2025.101347_bib174","doi-asserted-by":"crossref","DOI":"10.1093\/mmy\/myac038","article-title":"Cytokine response as a biomarker for early diagnosis and outcome prediction of stem cell transplant recipients and acute leukemia patients with invasive aspergillosis","volume":"60","author":"Puerta-Alcalde","year":"2022","journal-title":"Med. Mycol."},{"issue":"8","key":"10.1016\/j.mam.2025.101347_bib175","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"Rajasingham","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.mam.2025.101347_bib176","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(22)00499-6","article-title":"The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis","author":"Rajasingham","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.mam.2025.101347_bib177","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.1026067","article-title":"Does 18F-fdg PET\/CT Add value to conventional imaging in clinical assessment of chronic disseminated candidiasis?","volume":"9","author":"Rammaert","year":"2022","journal-title":"Front. Med."},{"issue":"24","key":"10.1016\/j.mam.2025.101347_bib178","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1056\/NEJMoa066906","article-title":"Anidulafungin versus fluconazole for invasive candidiasis","volume":"356","author":"Reboli","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.mam.2025.101347_bib179","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1056\/NEJM199411173312001","article-title":"A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia","volume":"331","author":"Rex","year":"1994","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.mam.2025.101347_bib180","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1086\/374850","article-title":"A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects","volume":"36","author":"Rex","year":"2003","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.mam.2025.101347_bib181","doi-asserted-by":"crossref","first-page":"R173","DOI":"10.1186\/cc8149","article-title":"Risk factors for acute respiratory distress syndrome during neutropenia recovery in patients with hematologic malignancies","volume":"13","author":"Rhee","year":"2009","journal-title":"Crit. Care"},{"key":"10.1016\/j.mam.2025.101347_bib182","doi-asserted-by":"crossref","unstructured":"Rhein, Joshua, Nathan C Bahr, Bozena M Morawski, Charlotte Schutz, Yonglong Zhang, Malcolm Finkelman, David B Meya, Graeme Meintjes, and David R Boulware. n.d. \u201cDetection of High Cerebrospinal Fluid Levels of (1\u21923)-\u03b2-D-Glucan in Cryptococcal Meningitis.\u201d.","DOI":"10.1093\/ofid\/ofu105"},{"issue":"6","key":"10.1016\/j.mam.2025.101347_bib183","doi-asserted-by":"crossref","first-page":"myad058","DOI":"10.1093\/mmy\/myad058","article-title":"The argentinian landscape of mycological diagnostic capacity and treatment accessibility","volume":"61","author":"Riera","year":"2023","journal-title":"Med. Mycol."},{"issue":"9","key":"10.1016\/j.mam.2025.101347_bib184","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1128\/JCM.01480-14","article-title":"Diagnosis of Pneumocystis jirovecii pneumonia in immunocompromised patients by real-time PCR: a 4-year prospective study","volume":"52","author":"Robert-Gangneux","year":"2014","journal-title":"J. Clin. Microbiol."},{"issue":"7","key":"10.1016\/j.mam.2025.101347_bib185","doi-asserted-by":"crossref","first-page":"e1302","DOI":"10.1093\/cid\/ciaa1189","article-title":"Immunosuppressive agents and infectious risk in transplantation: managing the \u2018net state of immunosuppression","volume":"73","author":"Roberts","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.mam.2025.101347_bib186","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin. Infect. Dis."},{"issue":"11","key":"10.1016\/j.mam.2025.101347_bib187","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/cid\/ciu596","article-title":"The effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitis","volume":"59","author":"Rolfes","year":"2014","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.mam.2025.101347_bib188","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/hon.2500","article-title":"Continuously infused amphotericin B deoxycholate for primary treatment of invasive fungal disease in acute myeloid leukaemia","volume":"36","author":"Rothenb\u00fchler","year":"2018","journal-title":"Hematol. Oncol."},{"issue":"11","key":"10.1016\/j.mam.2025.101347_bib189","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1007\/s00134-017-4932-8","article-title":"Biomarker-based strategy for early discontinuation of empirical antifungal treatment in critically Ill patients: a randomized controlled trial","volume":"43","author":"Rouz\u00e9","year":"2017","journal-title":"Intensive Care Med."},{"issue":"2","key":"10.1016\/j.mam.2025.101347_bib190","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/jac\/dkp430","article-title":"Forty-one recent cases of invasive Zygomycosis from a global clinical registry","volume":"65","author":"R\u00fcping","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"issue":"8","key":"10.1016\/j.mam.2025.101347_bib191","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/hiv.13268","article-title":"Major revision version 11.0 of the European AIDS clinical society guidelines 2021","volume":"23","author":"Ryom","year":"2022","journal-title":"HIV Med."},{"issue":"9","key":"10.1016\/j.mam.2025.101347_bib192","doi-asserted-by":"crossref","first-page":"792","DOI":"10.7326\/0003-4819-124-9-199605010-00003","article-title":"Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS: a double-blind, randomized trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine","volume":"124","author":"Safrin","year":"1996","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.mam.2025.101347_bib193","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106718","article-title":"The current state of laboratory mycology in Asia\/Pacific: a survey from the European confederation of medical mycology (ECMM) and international society for human and animal mycology (ISHAM)","volume":"61","author":"Salmanton-Garc\u00eda","year":"2023","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"1","key":"10.1016\/j.mam.2025.101347_bib194","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/S2666-5247(22)00261-0","article-title":"The current state of laboratory mycology and access to antifungal treatment in Europe: a European confederation of medical mycology survey","volume":"4","author":"Salmanton-Garc\u00eda","year":"2023","journal-title":"Lancet. Microb."},{"issue":"12","key":"10.1016\/j.mam.2025.101347_bib195","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/myc.13650","article-title":"The Austrian landscape of diagnostic capacity and access to treatment for invasive fungal infections","volume":"66","author":"Salmanton-Garc\u00eda","year":"2023","journal-title":"Mycoses"},{"issue":"4","key":"10.1016\/j.mam.2025.101347_bib196","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-109-4-280","article-title":"Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis Carinii pneumonia in the acquired immunodeficiency syndrome","volume":"109","author":"Sattler","year":"1988","journal-title":"Ann. Intern. Med."},{"issue":"8","key":"10.1016\/j.mam.2025.101347_bib197","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1080\/14740338.2021.1918673","article-title":"Risk of invasive fungal infections among patients treated with disease modifying treatments for multiple sclerosis: a comprehensive review","volume":"20","author":"Scotto","year":"2021","journal-title":"Expet Opin. Drug Saf."},{"issue":"5","key":"10.1016\/j.mam.2025.101347_bib198","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1086\/590566","article-title":"Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses study group and European organization for research and treatment of cancer consensus criteria","volume":"47","author":"Segal","year":"2008","journal-title":"Clin. Infect. Dis."},{"issue":"7","key":"10.1016\/j.mam.2025.101347_bib199","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/mmy\/myaa001","article-title":"Detection of rhizopus-specific antigen in human and murine serum and bronchoalveolar lavage","volume":"58","author":"Shibata","year":"2020","journal-title":"Med. Mycol."},{"issue":"3","key":"10.1016\/j.mam.2025.101347_bib200","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3109\/13693780903311944","article-title":"Primary treatment of zygomycosis with liposomal amphotericin B: analysis of 28 cases","volume":"48","author":"Shoham","year":"2010","journal-title":"Med. Mycol."},{"issue":"1","key":"10.1016\/j.mam.2025.101347_bib201","doi-asserted-by":"crossref","first-page":"ofad704","DOI":"10.1093\/ofid\/ofad704","article-title":"A systematic review of the therapeutic outcome of mucormycosis","volume":"11","author":"Sigera","year":"2024","journal-title":"Open Forum Infect. Dis."},{"issue":"6","key":"10.1016\/j.mam.2025.101347_bib202","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1128\/JCM.00773-12","article-title":"Correlation of clinical outcomes with \u03b2-glucan levels in patients with invasive candidiasis","volume":"50","author":"Sims","year":"2012","journal-title":"J. Clin. Microbiol."},{"issue":"12","key":"10.1016\/j.mam.2025.101347_bib203","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1086\/430606","article-title":"An immune reconstitution syndrome-like illness associated withCryptococcus neoformans infection in organ transplant recipients","volume":"40","author":"Singh","year":"2005","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.mam.2025.101347_bib204","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1086\/511438","article-title":"Cryptococcus neoformans in organ transplant recipients: impact of calcineurin\u2010inhibitor agents on mortality","volume":"195","author":"Singh","year":"2007","journal-title":"J. Infect. Dis."},{"issue":"10","key":"10.1016\/j.mam.2025.101347_bib205","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1086\/592690","article-title":"Immunocompromised hosts: cryptococcosis in solid organ transplant recipients: current state of the science","volume":"47","author":"Singh","year":"2008","journal-title":"Clin. Infect. Dis."},{"issue":"12","key":"10.1016\/j.mam.2025.101347_bib206","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/j.1469-0691.2010.03456.x","article-title":"Zygomycosis in europe: analysis of 230 cases accrued by the registry of the European confederation of medical mycology (ECMM) working group on zygomycosis between 2005 and 2007","volume":"17","author":"Skiada","year":"2011","journal-title":"Clin. Microbiol. Infection"},{"issue":"4","key":"10.1016\/j.mam.2025.101347_bib207","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3324\/haematol.2012.065110","article-title":"Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European conference on infections in leukemia (ECIL 3)","volume":"98","author":"Skiada","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.mam.2025.101347_bib208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/162576","article-title":"Importance of follow-up cerebrospinal fluid analysis in cryptococcal meningoencephalitis","volume":"2014","author":"Skripuletz","year":"2014","journal-title":"Dis. Markers"},{"issue":"1","key":"10.1016\/j.mam.2025.101347_bib209","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/jac\/dkab317","article-title":"When to change treatment of acute invasive aspergillosis: an expert viewpoint","volume":"77","author":"Slavin","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"issue":"12","key":"10.1016\/j.mam.2025.101347_bib210","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1001\/archinte.161.12.1529","article-title":"A meta-analysis of salvage therapy for Pneumocystis carinii pneumonia","volume":"161","author":"Smego","year":"2001","journal-title":"Arch. Intern. Med."},{"issue":"1","key":"10.1016\/j.mam.2025.101347_bib211","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00277-006-0167-4","article-title":"Unsuspected FDG\u2013PET findings in the follow-up of patients with lymphoma","volume":"86","author":"Sonet","year":"2007","journal-title":"Ann. Hematol."},{"issue":"4","key":"10.1016\/j.mam.2025.101347_bib212","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00002030-200003100-00011","article-title":"Discontinuation of secondary prophylaxis for opportunistic infections in HIV-infected patients receiving highly active antiretroviral therapy","volume":"14","author":"Soriano","year":"2000","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.mam.2025.101347_bib213","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/jac\/dkr375","article-title":"The deferasirox\u2013AmBisome therapy for mucormycosis (DEFEAT mucor) study: a randomized, double-blinded, placebo-controlled trial","volume":"67","author":"Spellberg","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"issue":"11","key":"10.1016\/j.mam.2025.101347_bib214","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1093\/cid\/civ154","article-title":"High resolution computed tomography angiography improves the radiographic diagnosis of invasive mold disease in patients with hematological malignancies","volume":"60","author":"Stanzani","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.mam.2025.101347_bib215","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jinf.2021.06.019","article-title":"Early low-dose computed tomography with pulmonary angiography to improve the early diagnosis of invasive mould disease in patients with haematological malignancies: a pilot study","volume":"83","author":"Stanzani","year":"2021","journal-title":"J. Infect."},{"issue":"7","key":"10.1016\/j.mam.2025.101347_bib216","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/myc.12919","article-title":"Mould-reactive T cells for the diagnosis of invasive mould infection\u2014a prospective study","volume":"62","author":"Steinbach","year":"2019","journal-title":"Mycoses"},{"issue":"11","key":"10.1016\/j.mam.2025.101347_bib217","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1086\/647948","article-title":"Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis","volume":"49","author":"Sun","year":"2009","journal-title":"Clin. Infect. Dis."},{"issue":"7","key":"10.1016\/j.mam.2025.101347_bib218","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1093\/cid\/ciaa1243","article-title":"Cryptococcal antigen in serum and cerebrospinal fluid for detecting cryptococcal meningitis in adults living with human immunodeficiency virus: systematic review and meta-analysis of diagnostic test accuracy studies","volume":"72","author":"Temfack","year":"2021","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.mam.2025.101347_bib219","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00019-23","article-title":"Fungal endocarditis: pathophysiology, epidemiology, clinical presentation, diagnosis, and management","volume":"36","author":"Thompson","year":"2023","journal-title":"Clin. Microbiol. Rev."},{"issue":"10370","key":"10.1016\/j.mam.2025.101347_bib220","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0140-6736(22)02324-8","article-title":"Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial","volume":"401","author":"Thompson","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.mam.2025.101347_bib221","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2018.00691","article-title":"Molecular imaging of invasive pulmonary aspergillosis using ImmunoPET\/MRI: the future looks bright","volume":"9","author":"Thornton","year":"2018","journal-title":"Front. Microbiol."},{"issue":"3","key":"10.1016\/j.mam.2025.101347_bib222","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3324\/haematol.2016.152900","article-title":"ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients","volume":"102","author":"Tissot","year":"2017","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.mam.2025.101347_bib223","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/cid\/ciab1028","article-title":"High false-positive rate of (1,3)-\u03b2-D-glucan in onco-hematological patients receiving immunoglobulins and therapeutic antibodies","volume":"75","author":"Tschopp","year":"2022","journal-title":"Clin. Infect. Dis."},{"issue":"May","key":"10.1016\/j.mam.2025.101347_bib224","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin. Microbiol. Infection"},{"issue":"1","key":"10.1016\/j.mam.2025.101347_bib78","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM199707033370103","article-title":"Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome","volume":"337","author":"van der Horst","year":"1997","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.mam.2025.101347_bib225","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1007\/s00330-016-4717-4","article-title":"Serial assessment of pulmonary lesion volume by computed tomography allows survival prediction in invasive pulmonary aspergillosis","volume":"27","author":"Vehreschild","year":"2017","journal-title":"Eur. Radiol."},{"issue":"4","key":"10.1016\/j.mam.2025.101347_bib226","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3390\/jof9040414","article-title":"Pneumocystis jirovecii pneumonia diagnostic approach: real-life experience in a tertiary centre","volume":"9","author":"Veintimilla","year":"2023","journal-title":"J. Fungi"},{"issue":"1","key":"10.1016\/j.mam.2025.101347_bib227","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s40121-020-00281-x","article-title":"Efficacy of a \u2018checklist\u2019 intervention bundle on the clinical outcome of patients with Candida bloodstream infections: a quasi-experimental pre-post study","volume":"9","author":"Vena","year":"2020","journal-title":"Infect. Dis. Ther."},{"issue":"1","key":"10.1016\/j.mam.2025.101347_bib228","doi-asserted-by":"crossref","first-page":"ofac656","DOI":"10.1093\/ofid\/ofac656","article-title":"Short course of antifungal therapy in patients with uncomplicated Candida bloodstream infection: another case of less is more in the clinical setting?","volume":"10","author":"Vena","year":"2023","journal-title":"Open Forum Infect. Dis."},{"issue":"5","key":"10.1016\/j.mam.2025.101347_bib229","doi-asserted-by":"crossref","first-page":"O336","DOI":"10.1111\/1469-0691.12408","article-title":"Local control of rhino-orbito-cerebral mucormycosis dramatically impacts survival","volume":"20","author":"Vironneau","year":"2014","journal-title":"Clin. Microbiol. Infection"},{"issue":"6","key":"10.1016\/j.mam.2025.101347_bib230","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.ejrad.2011.02.052","article-title":"HRCT-features of Pneumocystis Jiroveci pneumonia and their evolution before and after treatment in non-HIV immunocompromised patients","volume":"81","author":"Vogel","year":"2012","journal-title":"Eur. J. Radiol."},{"issue":"8","key":"10.1016\/j.mam.2025.101347_bib231","doi-asserted-by":"crossref","first-page":"ofy187","DOI":"10.1093\/ofid\/ofy187","article-title":"Epidemiology and clinical features of invasive fungal infection in a US Health care network","volume":"5","author":"Webb","year":"2018","journal-title":"Open Forum Infect. Dis."},{"issue":"1","key":"10.1016\/j.mam.2025.101347_bib232","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-105-1-37","article-title":"Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome","volume":"105","author":"Wharton","year":"1986","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"10.1016\/j.mam.2025.101347_bib233","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/cncr.22863","article-title":"Serum Aspergillus galactomannan antigen values strongly correlate with outcome of invasive aspergillosis","volume":"110","author":"Woods","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.mam.2025.101347_bib234","year":"2018"},{"issue":"10","key":"10.1016\/j.mam.2025.101347_bib235","doi-asserted-by":"crossref","first-page":"E396","DOI":"10.1111\/j.1469-0691.2012.03908.x","article-title":"Mucormycosis after allogeneic haematopoietic stem cell transplantation: a French multicentre cohort study (2003\u20132008)","volume":"18","author":"Xhaard","year":"2012","journal-title":"Clin. Microbiol. Infection"},{"issue":"8","key":"10.1016\/j.mam.2025.101347_bib236","doi-asserted-by":"crossref","DOI":"10.1097\/RLU.0b013e3181e4db84","article-title":"Utility of FDG PET\/CT in guiding antifungal therapy in acute leukemia patients with chronic disseminated candidiasis","volume":"35","author":"Xu","year":"2010","journal-title":"Clin. Nucl. Med."}],"container-title":["Molecular Aspects of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299725000111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299725000111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T04:42:46Z","timestamp":1748407366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0098299725000111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":235,"alternative-id":["S0098299725000111"],"URL":"https:\/\/doi.org\/10.1016\/j.mam.2025.101347","relation":{},"ISSN":["0098-2997"],"issn-type":[{"value":"0098-2997","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Duration of systemic antifungal therapy for patients with invasive fungal diseases: A reassessment","name":"articletitle","label":"Article Title"},{"value":"Molecular Aspects of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mam.2025.101347","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101347"}}